The effect of B cell depletion therapy on anti‐<scp>TSH</scp> receptor antibodies and clinical outcome in glucocorticoid‐refractory Graves' orbitopathy

Abstract

This case series adds to the growing literature demonstrating that RTX, administered in our patients with concomitant methylprednisolone, is safe and clinically effective in the treatment of active, moderate to severe and sight-threatening GO. Randomized controlled trials are now needed to confirm the efficacy of RTX for GO.